Gene signatures associated with drug resistance to irinotecan and oxaliplatin predict a poor prognosis in patients with colorectal cancer

The identification of novel survival predictors may help to improve the appropriate management of colorectal cancer (CRC). In the present study, two gene sets associated with irinotecan or oxaliplatin resistance in CRC cell lines were first identified and subsequently applied to the clinical CRC mic...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xinrong, Wang, Xiang, Feng, Wenming, Guo, Huihui, Tang, Chengwu, Lu, Yongliang, Xiang, Xiaobin, Bao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403337/
https://www.ncbi.nlm.nih.gov/pubmed/28454366
http://dx.doi.org/10.3892/ol.2017.5691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403337/
https://www.ncbi.nlm.nih.gov/pubmed/28454366
http://dx.doi.org/10.3892/ol.2017.5691

Ejemplares similares